TORONTO, Feb. 5, 2026 /CNW/ - Bravo Mining Corp. (TSXV: BRVO) (OTCQX: BRVMF) ("Bravo" or the "Company") is pleased to ...
Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果